Novartis Testing Strategies To Improve Pricing, Access To Certain Medicines In Developing Countries

Humanosphere: Drug companies test out new strategies for improving access in poor countries
David J. Olson, a global development communications and social marketing consultant, highlights how pharmaceutical company Novartis is trying to improve access to drugs for noncommunicable diseases in developing countries. The company has launched “Novartis Access, which is trying to find a commercial solution to the inherent tension between the need to get affordable medications to the poor and for drug companies to protect their bottom line, and intellectual property. It is also trying to address the need for training and health system strengthening…” (11/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.